Latanoprost Teva Sante

Latanoprost, the active ingredient in Latanoprost Teva Sante, is a prostaglandin analog presented as a eye drops for ocular use. It treats open-angle glaucoma and ocular hypertension in adult patients.

GNH USA supplies Latanoprost Teva Sante as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog used to lower intra‑ocular pressure in glaucoma‑related conditions.

Open-angle glaucoma: reduces intraocular pressure and helps preserve visual field. Ocular hypertension: lowers elevated eye pressure to prevent progression to glaucoma. Post‑surgical ocular pressure elevation: helps control pressure after eye surgery.

Latanoprost may cause ocular and systemic reactions.

Common Side Effects: - Eye redness or hyperemia - Eye irritation or foreign body sensation - Blurred vision - Increased eyelash growth - Darkening of the iris color - Mild eye discomfort

Serious or Rare Side Effects: - Severe allergic reaction with swelling or rash - Persistent eye pain with vision loss - Corneal ulceration or keratitis - Marked hypotony (very low intraocular pressure) - Acute uveitis or intraocular inflammation

Before using Latanoprost, consider the following safety measures.

Pregnancy: Category C – use only if potential benefit justifies the risk. Breastfeeding: Caution; limited data on excretion in milk. Active ocular infection: Avoid until infection resolved. Uveitis: Use with caution; monitor inflammation. Intraocular pressure monitoring: Check pressure after initiation and periodically. Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Concomitant use with other prostaglandin analogs – may cause excessive pressure reduction. - Combination with carbonic anhydrase inhibitors – additive intraocular pressure lowering. - Co‑administration with ophthalmic adrenergic agonists – may diminish therapeutic effect.

Moderate Interactions (Monitor Closely): - Use with non‑steroidal anti‑inflammatory eye drops – may increase ocular irritation. - Systemic beta‑blockers – potential additive hypotensive effect. - Anticholinergic eye drops – possible impact on tear film stability. - Contact lens solutions containing preservatives – may heighten irritation.